• Citer

Investigating the predictive value of topoisomerase II alpha (TOP2A) gene, mRNA and protein levels in anthracycline-treated estrogen receptor (ER) negative breast cancer patients.

par Desmedt, Christine ;de Azambuja, Evandro ;Larsimont, Denis ;Delaloge, Suzette;Duhem, Caroline;Rouas, Ghizlane;Di Leo, Angelo ;D'Hondt, Veronique ;Piccart-Gebhart, Martine ;Sotiriou, Christos
Référence ASCO - American Society of Clinical Oncology Annual Meeting(2008: Chicago, IL, USA), J Clin Oncol, Vol. 26: May 20 suppl;, page (abstr 11065)
Publication Publié, 2008-05

Publication dans des actes

• Détails

Titre:	Investigating the predictive value of topoisomerase II alpha (TOP2A) gene, mRNA and protein levels in anthracycline-treated estrogen receptor (ER) negative breast cancer patients.
Auteur:	Desmedt, Christine; de Azambuja, Evandro; Larsimont, Denis; Delaloge, Suzette; Duhem, Caroline; Rouas, Ghizlane; Di Leo, Angelo; D'Hondt, Veronique; Piccart-Gebhart, Martine; Sotiriou, Christos
Informations sur la publication:	ASCO - American Society of Clinical Oncology Annual Meeting(2008: Chicago, IL, USA), J Clin Oncol, Vol. 26: May 20 suppl;, page (abstr 11065)
Statut de publication:	Publié, 2008-05
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
	Sciences bio-médicales et agricoles
Langue:	Anglais